Annual Current Assets
$13.19 M
-$132.80 K-1.00%
June 1, 2024
Summary
- As of February 26, 2025, NEUP annual total current assets is $13.19 million, with the most recent change of -$132.80 thousand (-1.00%) on June 1, 2024.
- During the last 3 years, NEUP annual current assets has fallen by -$10.04 million (-43.22%).
Performance
NEUP Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Assets
$4.40 M
-$4.03 M-47.82%
December 1, 2024
Summary
- As of February 26, 2025, NEUP quarterly total current assets is $4.40 million, with the most recent change of -$4.03 million (-47.82%) on December 1, 2024.
- Over the past year, NEUP quarterly current assets has stayed the same.
Performance
NEUP Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
NEUP Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -1.0% | 0.0% |
3 y3 years | -43.2% | - |
5 y5 years | -25.0% | -63.4% |
NEUP Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -54.1% | at low | -86.4% | at low |
5 y | 5-year | -54.1% | -56.6% | -86.4% | at low |
alltime | all time | -69.6% | -98.9% | -90.1% | -16.4% |
Neuphoria Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | - | $4.40 M(-47.8%) |
Sep 2024 | - | $8.43 M(-36.1%) |
Jun 2024 | - | $13.19 M(+14.9%) |
Jun 2024 | $14.46 M(-5.1%) | - |
Dec 2023 | - | $11.48 M(-13.8%) |
Jun 2023 | $15.24 M(-5.7%) | $13.33 M(-40.9%) |
Dec 2022 | - | $22.55 M(-21.6%) |
Jun 2022 | $16.17 M(-7.8%) | $28.76 M(-11.0%) |
Dec 2021 | - | $32.33 M(+39.1%) |
Jun 2021 | $17.53 M(-2.3%) | $23.24 M(+352.8%) |
Dec 2020 | - | $5.13 M(-10.4%) |
Jun 2020 | $17.95 M(-10.1%) | $5.73 M(-52.4%) |
Dec 2019 | - | $12.02 M(-31.7%) |
Jun 2019 | $19.98 M(-6.7%) | $17.60 M(-25.0%) |
Dec 2018 | - | $23.45 M(-11.1%) |
Jun 2018 | $21.41 M(-5.9%) | $26.39 M(-26.9%) |
Dec 2017 | - | $36.09 M(-13.8%) |
Jun 2017 | $22.74 M(+1.8%) | $41.86 M(+16.3%) |
Dec 2016 | - | $36.00 M(-17.0%) |
Jun 2016 | $22.35 M(-6.8%) | $43.38 M(-2.5%) |
Dec 2015 | - | $44.50 M(+53.2%) |
Jun 2015 | $23.97 M(-0.3%) | $29.05 M(-19.4%) |
Dec 2014 | - | $36.06 M(-3.1%) |
Jun 2014 | $24.05 M(+15.1%) | $37.21 M(+66.7%) |
Dec 2013 | - | $22.32 M(-20.4%) |
Jun 2013 | $20.89 M | $28.03 M(+56.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2012 | - | $17.97 M(-19.2%) |
Jun 2012 | $9.58 M(-4.8%) | $22.25 M(+14.1%) |
Dec 2011 | - | $19.51 M(-26.7%) |
Jun 2011 | $10.07 M(-32.7%) | $26.60 M(+56.1%) |
Dec 2010 | - | $17.04 M(+44.3%) |
Jun 2010 | $14.97 M(-1.5%) | $11.81 M(-21.0%) |
Dec 2009 | - | $14.95 M(+214.6%) |
Jun 2009 | $15.20 M(-18.3%) | $4.75 M(+29.1%) |
Dec 2008 | - | $3.68 M(-56.6%) |
Jun 2008 | $18.62 M(+30.1%) | $8.47 M(+2.1%) |
Dec 2007 | - | $8.30 M(-29.9%) |
Jun 2007 | $14.31 M(+32.4%) | $11.84 M(+101.4%) |
Dec 2006 | - | $5.88 M(+53.5%) |
Jun 2006 | $10.80 M(+86.1%) | $3.83 M(-24.5%) |
Dec 2005 | - | $5.07 M(-29.6%) |
Jun 2005 | $5.80 M(+38.6%) | $7.20 M(+20.4%) |
Dec 2004 | - | $5.98 M(-4.7%) |
Jun 2004 | $4.19 M(-2.4%) | $6.27 M(+62.3%) |
Dec 2003 | - | $3.86 M(-7.6%) |
Jun 2003 | $4.29 M(+8.8%) | $4.18 M(+8.0%) |
Dec 2002 | - | $3.87 M(-22.2%) |
Jun 2002 | $3.94 M(+793.0%) | $4.97 M(-8.7%) |
Dec 2001 | - | $5.45 M(+7.2%) |
Jun 2001 | $441.70 K(+19.4%) | $5.08 M(+14.0%) |
Dec 2000 | - | $4.46 M |
Jun 2000 | $369.90 K(>+9900.0%) | - |
Jun 1999 | $0.00 | - |
FAQ
- What is Neuphoria Therapeutics annual total current assets?
- What is the all time high annual current assets for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics annual current assets year-on-year change?
- What is Neuphoria Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics quarterly current assets year-on-year change?
What is Neuphoria Therapeutics annual total current assets?
The current annual current assets of NEUP is $13.19 M
What is the all time high annual current assets for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high annual total current assets is $43.38 M
What is Neuphoria Therapeutics annual current assets year-on-year change?
Over the past year, NEUP annual total current assets has changed by -$132.80 K (-1.00%)
What is Neuphoria Therapeutics quarterly total current assets?
The current quarterly current assets of NEUP is $4.40 M
What is the all time high quarterly current assets for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high quarterly total current assets is $44.50 M
What is Neuphoria Therapeutics quarterly current assets year-on-year change?
Over the past year, NEUP quarterly total current assets has changed by $0.00 (0.00%)